DOI:
10.1055/s-00000094
Zeitschrift für Gastroenterologie
LinksClose Window
References
Kwo P, Gane E, Peng CY. et al.
Efficacy and safety of Grazoprevir/Elbasvir plus/–RBV for 12 weeks in patients with HCV G1 or G4 infection who previously failed peginterferon/RBV: C-EDGE treatment-experienced trial.
Journal of hepatology 2015;
62: S674-S675
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.